Efficacy and safety of brentuximab vedotin plus bendamustine in advanced‐stage primary cutaneous T‐cell lymphomas
暂无分享,去创建一个
C. Lebbé | M. Bagot | I. Madelaine | M. Battistella | P. Brice | R. Peffault de Latour | H. Moins-Teisserenc | J. Bouaziz | J. Delyon | F. Herms | A. Masson | M. Roelens | M. Dumont | C. Ram-Wolff